FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566338947> ?p ?o ?g. }

• W1566338947 endingPage "1202" @default.
• W1566338947 startingPage "1193" @default.
• W1566338947 abstract "Increased levels of glutamate causing excitotoxic damage accompany many neurological disorders. A well-characterized model of excitotoxic damage involves administration of kainic acid (KA), which causes limbic seizure activity and subsequent neuronal death, particularly in the CA1 and CA3 areas of the hippocampus. Inhibition of the enzyme glycogen synthase kinase-3 (GSK-3) and cAMP levels might play an important role in neuroprotection. As intracellular cAMP levels depend, in part, on the activity of the phosphodiesterase enzymes (PDEs), these enzymes have recently emerged as potential therapeutic targets for the treatment of several diseases. In previous works, we have shown a potent anti-inflammatory and neuroprotective effect of GSK-3 inhibition in a model of excitotoxicity, as well as a reduction of nigrostriatal dopaminergic neuronal cell death after phosphodiesterase 7 inhibition, which leads to an increase in cAMP levels. This study was undertaken to determine whether simultaneous inhibition of GSK-3 and PDE-7 by a novel 5-imino-1,2,4-thiadiazole compound, named VP1.14, could prevent the massive neuronal loss in the hippocampus evoked by intrahippocampal injection of KA. Here, we show that rats treated with VP1.14 showed a reduced inflammatory response after KA injection, and exhibited a significant reduction in pyramidal cell loss in the CA1 and CA3 areas of the hippocampus. Studies with hippocampal HT22 cells in vitro also showed a clear neuroprotective effect of VP1.14 and an anti-inflammatory effect shown by a decrease in the nitrite liberation and in the expression of pro-inflammatory cytokines by primary cultures of astrocytes treated with lipopolysaccharide." @default.
• W1566338947 created "2016-06-24" @default.
• W1566338947 creator A5005086687 @default.
• W1566338947 creator A5017531896 @default.
• W1566338947 creator A5021512226 @default.
• W1566338947 creator A5028669057 @default.
• W1566338947 creator A5034947054 @default.
• W1566338947 creator A5049432626 @default.
• W1566338947 creator A5060896107 @default.
• W1566338947 creator A5064670942 @default.
• W1566338947 creator A5081079756 @default.
• W1566338947 creator A5083312471 @default.
• W1566338947 date "2012-08-03" @default.
• W1566338947 modified "2023-10-18" @default.
• W1566338947 title "The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury" @default.
• W1566338947 cites W111663151 @default.
• W1566338947 cites W1496973986 @default.
• W1566338947 cites W1566528879 @default.
• W1566338947 cites W1589018486 @default.
• W1566338947 cites W1965126541 @default.
• W1566338947 cites W1970308606 @default.
• W1566338947 cites W1972504460 @default.
• W1566338947 cites W1989771058 @default.
• W1566338947 cites W1990270711 @default.
• W1566338947 cites W2006904109 @default.
• W1566338947 cites W2010233543 @default.
• W1566338947 cites W2014091183 @default.
• W1566338947 cites W2016293448 @default.
• W1566338947 cites W2025806359 @default.
• W1566338947 cites W2026524798 @default.
• W1566338947 cites W2033023603 @default.
• W1566338947 cites W2038884088 @default.
• W1566338947 cites W2046047511 @default.
• W1566338947 cites W2051503181 @default.
• W1566338947 cites W2053937836 @default.
• W1566338947 cites W2054333837 @default.
• W1566338947 cites W2058063216 @default.
• W1566338947 cites W2061072280 @default.
• W1566338947 cites W2065089671 @default.
• W1566338947 cites W2068412840 @default.
• W1566338947 cites W2068568529 @default.
• W1566338947 cites W2070616314 @default.
• W1566338947 cites W2071553665 @default.
• W1566338947 cites W2072682099 @default.
• W1566338947 cites W2075374965 @default.
• W1566338947 cites W2079311820 @default.
• W1566338947 cites W2079660714 @default.
• W1566338947 cites W2082879602 @default.
• W1566338947 cites W2085251042 @default.
• W1566338947 cites W2085457897 @default.
• W1566338947 cites W2088771963 @default.
• W1566338947 cites W2092331056 @default.
• W1566338947 cites W2100042702 @default.
• W1566338947 cites W2104479866 @default.
• W1566338947 cites W2114918609 @default.
• W1566338947 cites W2125790709 @default.
• W1566338947 cites W2133704905 @default.
• W1566338947 cites W2138152051 @default.
• W1566338947 cites W2142975609 @default.
• W1566338947 cites W2168367599 @default.
• W1566338947 cites W2170892398 @default.
• W1566338947 doi "https://doi.org/10.1111/j.1471-4159.2012.07866.x" @default.
• W1566338947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22774807" @default.
• W1566338947 hasPublicationYear "2012" @default.
• W1566338947 type Work @default.
• W1566338947 sameAs 1566338947 @default.
• W1566338947 citedByCount "14" @default.
• W1566338947 countsByYear W15663389472013 @default.
• W1566338947 countsByYear W15663389472014 @default.
• W1566338947 countsByYear W15663389472015 @default.
• W1566338947 countsByYear W15663389472016 @default.
• W1566338947 countsByYear W15663389472019 @default.
• W1566338947 countsByYear W15663389472020 @default.
• W1566338947 countsByYear W15663389472021 @default.
• W1566338947 countsByYear W15663389472022 @default.
• W1566338947 countsByYear W15663389472023 @default.
• W1566338947 crossrefType "journal-article" @default.
• W1566338947 hasAuthorship W1566338947A5005086687 @default.
• W1566338947 hasAuthorship W1566338947A5017531896 @default.
• W1566338947 hasAuthorship W1566338947A5021512226 @default.
• W1566338947 hasAuthorship W1566338947A5028669057 @default.
• W1566338947 hasAuthorship W1566338947A5034947054 @default.
• W1566338947 hasAuthorship W1566338947A5049432626 @default.
• W1566338947 hasAuthorship W1566338947A5060896107 @default.
• W1566338947 hasAuthorship W1566338947A5064670942 @default.
• W1566338947 hasAuthorship W1566338947A5081079756 @default.
• W1566338947 hasAuthorship W1566338947A5083312471 @default.
• W1566338947 hasBestOaLocation W15663389471 @default.
• W1566338947 hasConcept C148762608 @default.
• W1566338947 hasConcept C169760540 @default.
• W1566338947 hasConcept C170493617 @default.
• W1566338947 hasConcept C181199279 @default.
• W1566338947 hasConcept C182996813 @default.
• W1566338947 hasConcept C184235292 @default.
• W1566338947 hasConcept C185592680 @default.
• W1566338947 hasConcept C190283241 @default.
• W1566338947 hasConcept C25498285 @default.
• W1566338947 hasConcept C2776108384 @default.

• next